Literature DB >> 23540876

The Berlin definition of ARDS versus pathological evidence of diffuse alveolar damage.

B Taylor Thompson, Michael A Matthay.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23540876     DOI： 10.1164/rccm.201302-0385ed

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  23 in total

Review 1.  Emerging therapies for the prevention of acute respiratory distress syndrome.

Authors:  Carl A Ruthman; Emir Festic
Journal:  Ther Adv Respir Dis       Date:  2015-05-22       Impact factor: 4.031

2.  Open lung biopsy in nonresolving ARDS frequently identifies diffuse alveolar damage regardless of the severity stage and may have implications for patient management.

Authors:  Claude Guerin; Frédérique Bayle; Véronique Leray; Sophie Debord; Alina Stoian; Hodane Yonis; Jean-Baptiste Roudaut; Gael Bourdin; Mojgan Devouassoux-Shisheboran; Elodie Bucher; Louis Ayzac; Sylvie Lantuejoul; Carole Philipponnet; Jean Louis Kemeny; Bertrand Souweine; Jean-Christophe Richard
Journal:  Intensive Care Med       Date:  2014-12-05       Impact factor: 17.440

Review 3.  COVID-19-Associated Acute Respiratory Distress Syndrome: Lessons from Tissues and Cells.

Authors:  Elizabeth A Middleton; Guy A Zimmerman
Journal:  Crit Care Clin       Date:  2021-05-26       Impact factor: 3.598

4.  Acute respiratory distress syndrome in patients with and without diffuse alveolar damage: an autopsy study.

Authors:  José A Lorente; Pablo Cardinal-Fernández; Diego Muñoz; Fernando Frutos-Vivar; Arnaud W Thille; Carlos Jaramillo; Aida Ballén-Barragán; José M Rodríguez; Oscar Peñuelas; Guillermo Ortiz; José Blanco; Bruno Valle Pinheiro; Nicolás Nin; María del Carmen Marin; Andrés Esteban; Taylor B Thompson
Journal:  Intensive Care Med       Date:  2015-09-18       Impact factor: 17.440

Review 5.  What every intensivist should know about acute respiratory distress syndrome and diffuse alveolar damage.

Authors:  Fernando Rios; Teresa Iscar; Pablo Cardinal-Fernández
Journal:  Rev Bras Ter Intensiva       Date:  2017-09-28

6.  Pseudomonas aeruginosa Ventilator-Associated Pneumonia Rabbit Model for Preclinical Drug Development.

Authors:  Nhu T Q Nguyen; Emmanuelle Gras; Nguyen D Tran; Nhi N Y Nguyen; Hanh T H Lam; William J Weiss; Thien N M Doan; Binh An Diep
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

7.  Is there a need for emerging drugs for the acute respiratory distress syndrome?

Authors:  Marianne Fitzgerald; Daniel F McAuley; Michael Matthay
Journal:  Expert Opin Emerg Drugs       Date:  2014-08-24       Impact factor: 4.191

8.  Surfactant protein-A nanobody-conjugated liposomes loaded with methylprednisolone increase lung-targeting specificity and therapeutic effect for acute lung injury.

Authors:  Nan Li; Dong Weng; Shan-Mei Wang; Yuan Zhang; Shan-Shan Chen; Zhao-Fang Yin; Jiali Zhai; Judy Scoble; Charlotte C Williams; Tao Chen; Hui Qiu; Qin Wu; Meng-Meng Zhao; Li-Qin Lu; Xavier Mulet; Hui-Ping Li
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

9.  Is there still a role for the lung injury score in the era of the Berlin definition ARDS?

Authors:  Kirsten Neudoerffer Kangelaris; Carolyn S Calfee; Addison K May; Hanjing Zhuo; Michael A Matthay; Lorraine B Ware
Journal:  Ann Intensive Care       Date:  2014-02-18       Impact factor: 6.925

10.  Perceptions of diagnosis and management of patients with acute respiratory distress syndrome: a survey of United Kingdom intensive care physicians.

Authors:  Ahilanandan Dushianthan; Rebecca Cusack; Nigel Chee; John-Oliver Dunn; Michael P W Grocott
Journal:  BMC Anesthesiol       Date:  2014-10-02       Impact factor: 2.217
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.